Premium
Celldex Therapeutics Inc (CLDX)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung c... Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.89 | -4.17644298451 | 21.31 | 21.85 | 18.95 | 839081 | 20.45434287 | CS |
| 4 | -2.86 | -12.2852233677 | 23.28 | 23.69 | 18.61 | 717074 | 20.92301067 | CS |
| 12 | -4.76 | -18.9038919778 | 25.18 | 29.05 | 18.61 | 899078 | 23.48763 | CS |
| 26 | -23.82 | -53.842676311 | 44.24 | 47 | 18.61 | 1060284 | 27.71438979 | CS |
| 52 | -24.63 | -54.6725860155 | 45.05 | 47 | 18.61 | 865893 | 31.94070883 | CS |
| 156 | -10.98 | -34.9681528662 | 31.4 | 53.18 | 18.61 | 707011 | 33.20526992 | CS |
| 260 | 18.64 | 1047.19101124 | 1.78 | 57.2 | 1.5 | 797900 | 26.83644247 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
